TABLE OF CONTENTS
Executive Summary 7
Industry analysis 7
Industry definition 7
Research highlights 7
Top 10 companies landscape 8
Market Value 9
Market Forecast 10
Market Segmentation—Product 11
Market Segmentation—Geographic 12
Five Forces Analysis 13
Summary 13
Buyer power 14
Supplier power 15
New entrants 16
Substitutes 17
Rivalry 18
Top 10 Companies Landscape 19
Revenue analysis 23
Financial performance analysis 25
Company Reports 30
Amgen 30
Genentech 35
Gilead Sciences 40
UCB 44
Genzyme 49
Biogen Idec 54
CSL 58
Celgene 63
Cephalon 67
Actelion 71
Financial Analysis 75
Amgen 75
Genentech 78
Gilead Sciences 81
UCB 84
Genzyme 87
Biogen Idec 90
CSL 93
Celgene 96
Cephalon 99
Actelion 102
Appendix 105


FIGURES
Figure 1: Global biotechnology market, $ million, 2003–07 9
Figure 2: Global biotechnology market forecast, $ million, 2007–12 10
Figure 3: Global biotechnology market segmentation—product, % share, 2007 11
Figure 4: Global biotechnology market segmentation—geography, % share, 2007 12
Figure 5: Forces driving competition in the global biotechnology market 13
Figure 6: Drivers of buyer power in the global biotechnology market 14
Figure 7: Drivers of supplier power in the global biotechnology market 15
Figure 8: Factors influencing the likelihood of new entrants in the global biotechnology market 16
Figure 9: Factors influencing the threat of substitutes in the global biotechnology market 17
Figure 10: Drivers of degree of rivalry in the global biotechnology market 18
Figure 11: Revenues of global top 10 biotechnology companies, $ million, FY2008 20
Figure 12: Revenue growth of global top 10 biotechnology companies, 2006–08 24
Figure 13: Operating performance analysis, FY2008 26
Figure 14: Net profit analysis, FY2008 27

TABLES
Table 1: Global biotechnology market, $ million, 2003–07 9
Table 2: Global biotechnology market forecast, $ million, 2007–12 10
Table 3: Global biotechnology market segmentation—product , % share, 2007 11
Table 4: Global biotechnology market segmentation—geography, % share, 2007 12
Table 5: Revenues of global top 10 biotechnology companies, $ million, FY2008 19
Table 6: Revenue growth of global top 10 biotechnology companies, 2006–08 23
Table 7: Key financials of global top 10 biotechnology companies, FY2008 25
Table 8: Key industry specific ratios, FY2008 28
Table 9: Amgen—Financial and operational highlights, 2004–08 ($ million) 75
Table 10: Amgen—Key industry specific ratios, 2004–2008 77
Table 11: Genentech—Financial and operational highlights, 2004–08 ($ million) 78
Table 12: Genentech—Key industry specific ratios, 2004–08 80
Table 13: Gilead Sciences—Financial and operational highlights, 2004–08 ($ million) 81
Table 14: Gilead Sciences—Key industry specific ratios, 2004–08 83
Table 19: UCB—Financial and operational highlights, 2004–08 ($ million) 84
Table 20: UCB—Key industry specific ratios, 2004–08 86
Table 15: Genzyme—Financial and operational highlights, 2004–08 ($ million) 87
Table 16: Genzyme—Key industry specific ratios, 2004–08 89
Table 17: Biogen Idec—Financial and operational highlights, 2004–08 ($ million) 90
Table 18: Biogen Idec—Key industry specific ratios, 2004–08 92
Table 21: CSL—Financial and operational highlights, 2004–08 ($ million) 93
Table 22: CSL—Key industry specific ratios, 2004–08 95
Table 23: Celgene— Financial and operational highlights, 2004–08 ($ million) 96
Table 24: Celgene—Key industry specific ratios, 2004–08 98
Table 25: Cephalon—Financial and operational highlights, 2004–2008 ($ million) 99
Table 26: Cephalon—Key industry specific ratios, 2004–08 101
Table 27: Actelion—Financial and operational highlights, 2004–08 ($ million) 102
Table 28: Actelion—Key industry specific ratios, 2004–08 104